Mai 2014 - IOZK

Association of increased progression-free survival in primary glioblastomas with lymphopenia at baseline and activation of NK and NKT cells after dendritic cell immunotherapy.

2014-05-31/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-31 / J Clin Oncol 32:5s, 2014 (suppl; abstr 2087)

Dendritic cell vaccination in malignant pleural mesothelioma: A phase I/II study.

2014-05-31/in Dendritic Cells, International Publications /von 2014-05-31 / J Clin Oncol 32:5s, 2014 (suppl; abstr 7583)

A feasibility and safety study of vaccination with poly-ICLC and peptide-pulsed dendritic cells in patients with metastatic, locally advanced unresectable, or recurrent pancreatic adenocarcinoma.

2014-05-30/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2014-05-30 / J Clin Oncol 32, 2014 (suppl; abstr e15254)

Dendritic cell immunotherapy for glioblastoma

2014-05-21/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-21 / Expert Rev Anticancer Ther 2014 Jul;14(7):761-3

Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective

2014-05-16/in Dendritic Cells, International Publications /von 2014-05-16 / Expert Opin Biol Ther 2014 Sep;14(9):1259-70

The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell lines

2014-05-13/in Hyperthermia, International Publications /von 2014-05-13 / J Clin Biochem Nutr 2014 Jul;55(1):56-61

Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients

2014-05-13/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-13 / J Immunother Cancer 2014;2:10

Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells

2014-05-13/in Dendritic Cells, International Publications, IOZK Veröffentlichungen /von 2014-05-13 / Cytotherapy 2014 Jul;16(7):946-64

Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer

2014-05-12/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-05-12 / Virol. J. 2014 May;11:84

The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer

2014-05-07/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-05-07 / J Ovarian Res 2014 May;7:48